Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

Update Il y a 4 ans
Reference: NCT02425111

Woman and Man

Extract

The purpose of this study is to evaluate endoscopic remission at Week 26 as assessed by ileocolonoscopy.


Inclusion criteria

  • Crohn’s Disease


Links